Amphion Innovations PLC Director/PDMR Shareholding (7615N)
03 Octubre 2012 - 1:00AM
UK Regulatory
TIDMAMP
RNS Number : 7615N
Amphion Innovations PLC
03 October 2012
Directors' Dealings
Directors Receive Shares in Lieu of Fees
London and New York, 2 October 2012- Amphion Innovations plc
(the "Company") (LSE: AMP), the developer of medical and technology
businesses, announces that the Company has today issued 226,083
ordinary shares, representing 0.17% of the enlarged issued share
capital, to certain of its Board members as their directors' fees
for the third quarter of 2012, priced at 2.675 pence, being the
average of the closing mid-market price for the five days leading
up to the market close on 28 September 2012. Following this issue,
the directors' shareholdings in the Company are as follows:
Director Number of New Shares Total Shareholding Percentage of voting rights
R. James Macaleer 176,083 23,978,945 17.684%
Gerard Moufflet 50,000 700,000 0.516%
Director, Anthony Henfrey waived his fees for the third quarter
of 2012.
Admission of the 226,083 new ordinary shares, ranking pari passu
with the existing ordinary shares, is expected on 8 October 2012.
Following this allotment the total issued share capital of the
Company will increase to 135,600,250 ordinary shares with each
share holding one voting right.
For further information please contact:
Amphion Innovations
Charlie Morgan:
+1 212 210 6224
Seymour Pierce Limited
Mark Percy (Corporate Finance)
David Banks (Corporate Broking)
+44 020 7107 8000
Cardew Group
Tim Robertson
+44 020 7930 0777
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSELLFBLBFEFBK
Amphion Innovations (LSE:AMP)
Gráfica de Acción Histórica
De Jul 2024 a Ago 2024
Amphion Innovations (LSE:AMP)
Gráfica de Acción Histórica
De Ago 2023 a Ago 2024
Real-Time news about Amphion Innovations Plc (London Stock Exchange): 0 recent articles
Más de Amphion Artículos de Noticias